Cargando…

Locally Performed HRD Testing for Ovarian Cancer? Yes, We Can!

SIMPLE SUMMARY: Poly (ADP-ribose) polymerase inhibitors (PARPis) have been recently approved by international medicine agencies for the treatment of ovarian cancer patients with either BRCA pathogenic variants or homologous recombination deficiency (HRD), changing the ovarian cancer treatment landsc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Magliacane, Gilda, Brunetto, Emanuela, Calzavara, Silvia, Bergamini, Alice, Pipitone, Giovanni Battista, Marra, Giovanna, Redegalli, Miriam, Grassini, Greta, Rabaiotti, Emanuela, Taccagni, Gianluca, Pecciarini, Lorenza, Carrera, Paola, Mangili, Giorgia, Doglioni, Claudio, Cangi, Maria Giulia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9817883/ https://www.ncbi.nlm.nih.gov/pubmed/36612041 http://dx.doi.org/10.3390/cancers15010043

Ejemplares similares

Gene Fusion Detection in NSCLC Routine Clinical Practice: Targeted-NGS or FISH?
por: Pecciarini, Lorenza, et al.
Publicado: (2023)

Epithelial ovarian cancer is infiltrated by activated effector T cells co-expressing CD39, PD-1, TIM-3, CD137 and interacting with cancer cells and myeloid cells
por: Tassi, Elena, et al.
Publicado: (2023)

Rapid targeted somatic mutation analysis of solid tumors in routine clinical diagnostics
por: Magliacane, Gilda, et al.
Publicado: (2015)

Endometriosis-Related Ovarian Cancers: Evidence for a Dichotomy in the Histogenesis of the Two Associated Histotypes
por: Bergamini, Alice, et al.
Publicado: (2023)

Next Generation Sequencing in Non-Small Cell Lung Cancer: Pitfalls and Opportunities
por: Lazzari, Chiara, et al.
Publicado: (2020)

Current Evidence on Immunotherapy for Gestational Trophoblastic Neoplasia (GTN)
por: Mangili, Giorgia, et al.
Publicado: (2022)

A rare case of a giant arterio-venous fistula (AVF) following metastatic choriocarcinoma conditioning pulmonary embolism: multimodal transcatheter embolization using a simultaneous transarterial and transvenous approach
por: Venturini, Massimo, et al.
Publicado: (2018)

Correction to: A rare case of a giant arterio-venous fistula (AVF) following metastatic choriocarcinoma conditioning pulmonary embolism: multimodal transcatheter embolization using a simultaneous transarterial and transvenous approach
por: Venturini, Massimo, et al.
Publicado: (2020)

Intratumoral Cellular Heterogeneity: Implications for Drug Resistance in Patients with Non-Small Cell Lung Cancer
por: Gregorc, Vanesa, et al.
Publicado: (2021)

Role of Machine Learning (ML)-Based Classification Using Conventional (18)F-FDG PET Parameters in Predicting Postsurgical Features of Endometrial Cancer Aggressiveness
por: Bezzi, Carolina, et al.
Publicado: (2023)

Case report: EML4::NTRK3 gene fusion in a patient with metastatic lung adenocarcinoma successfully treated with entrectinib
por: Lazzari, Chiara, et al.
Publicado: (2022)

Socio-demographic and psychological factors associated with quality of life of women undergoing chemotherapy treatment for gynecological cancer
por: Di Mattei, Valentina E., et al.
Publicado: (2022)

Paclitaxel and concomitant radiotherapy in high-risk endometrial cancer patients: preliminary findings
por: Mangili, Giorgia, et al.
Publicado: (2006)

Implementing HRD technology /
Publicado: (1999)

Cryo-EM structure of the protein-conducting ERAD channel Hrd1 in complex with Hrd3
por: Schoebel, Stefan, et al.
Publicado: (2017)

“Health in the Mirror”: An Unconventional Approach to Unmet Psychological Needs in Oncology
por: Di Mattei, Valentina E., et al.
Publicado: (2017)

Ovarian Cancer Radiosensitivity: What Have We Understood So Far?
por: Barcellini, Amelia, et al.
Publicado: (2022)

Endoplasmic Reticulum Degradation Requires Lumen to Cytosol Signaling: Transmembrane Control of Hrd1p by Hrd3p
por: Gardner, Richard G., et al.
Publicado: (2000)

A Hrd way for MHC-II expression
por: Melo-Cardenas, Johanna, et al.
Publicado: (2015)

Homologous Recombination Deficiency (HRD) in Cutaneous Oncology
por: Akinjiyan, Favour A., et al.
Publicado: (2023)

The prevalence of homologous recombination deficiency (HRD) in various solid tumors and the role of HRD as a single biomarker to immune checkpoint inhibitors
por: Kim, Hana, et al.
Publicado: (2021)

Proposal for a New Pathologic Prognostic Index After Neoadjuvant Chemotherapy in Pancreatic Ductal Adenocarcinoma (PINC)
por: Redegalli, M., et al.
Publicado: (2022)

Yes
por: Stanley, Arthur
Publicado: (1923)

The role of Hrd1 in ultraviolet (UV) radiation induced photoaging
por: Jin, Yi, et al.
Publicado: (2020)

Increased HRD score in cisplatin resistant penile cancer cells
por: Winkelmann, Ria, et al.
Publicado: (2022)

Opinion: Yes
por: Vieira, Marcelo
Publicado: (2015)

Opinion: Yes
por: Althof, Stanley E.
Publicado: (2015)

Opinion: Yes
por: Cintra, Caio Cesar, et al.
Publicado: (2016)

Yes, It Does
por: Cummins, Nathan W.
Publicado: (2021)

Hurconomics for Talent Management: The Creation of a Business-driven HRD Missionary
por: Rao, T
Publicado: (2011)

Herp coordinates compartmentalization and recruitment of HRD1 and misfolded proteins for ERAD
por: Leitman, Julia, et al.
Publicado: (2014)

Proteomic characterization of endogenous substrates of mammalian ubiquitin ligase Hrd1
por: Ye, Yilin, et al.
Publicado: (2018)

Putative Interaction Proteins of the Ubiquitin Ligase Hrd1 in Magnaporthe oryzae
por: Jiang, Haolang, et al.
Publicado: (2018)

DNA mapping and kinetic modeling of the HrdB regulon in Streptomyces coelicolor
por: Šmídová, Klára, et al.
Publicado: (2019)

Cycles of autoubiquitination and deubiquitination regulate the ERAD ubiquitin ligase Hrd1
por: Peterson, Brian G, et al.
Publicado: (2019)

HRD-related morphology discovery in breast cancer by controlling for confounding factors
por: Schirris, Yoni, et al.
Publicado: (2022)

HRD Testing of Ovarian Cancer in Routine Practice: What Are We Dealing With?
por: Kekeeva, Tatiana, et al.
Publicado: (2023)

Current scenario of the genetic testing for rare neurological disorders exploiting next generation sequencing
por: Di Resta, Chiara, et al.
Publicado: (2020)

Modularity of the Hrd1 ERAD complex underlies its diverse client range
por: Kanehara, Kazue, et al.
Publicado: (2010)

Proteasomal Degradation of Proinsulin Requires Derlin-2, HRD1 and p97
por: Hoelen, Hanneke, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_tmrfbtbn5s1lfbt6c78kt1nduc